Stillwell Richard Newcomb
SEC insider (Form 3/4/5 filer). CIK 0001966861. Director at Tonix Pharmaceuticals Holding Corp. (TNXP). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Stillwell Richard Newcomb has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Director
Stillwell Richard Newcomb
CIK: 0001966861
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TNXP
Tonix Pharmaceuticals Holding Corp.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 8, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect5K shares at avg. $11.65$58K - May 12, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
22.7K shares- - May 13, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
10K shares-
1-3 of 3 transactions